Caroline BRET

Has grant

MCU-PH, head of the Flow Cytometry Laboratory

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Caroline BRET is an Associate Professor at CHU and University in France, where she leads the Flow Cytometry Laboratory. Her research focuses on the role of transcriptional repressors in physiological processes and tumor development, along with the immunophenotypic characterization of lymphomas and leukemia. Recent publications highlight advancements in single-cell analysis, targeted therapies in multiple myeloma, and the implications of cellular iron homeostasis in diffuse large B-cell lymphoma.

Recent Grants

Grant: Close

DNA repair in B cell lymphomas

Open Date:

Close Date:

Articles (12)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (7)

Raúl F. Pérez

Associate professor

Universidad Complutense de Madrid

SPAIN

View details

Ludovic Gabellier

FRANCE

View details

Blandine GUFFROY

Institut de Cancérologie Strasbourg

FRANCE

View details

thierry fest

university hospital of Rennes

FRANCE

View details

Jerome Moreaux

Professor

University of Montpellier

FRANCE

View details

sylvain carras

Professeur des Universités - Praticien Hospitalier

Grenoble Alpes University Hospital

FRANCE

View details

José Labarere

University of Birmingham

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Caroline BRET

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (12)

CD38, CD39, and BCL2 differentiate disseminated forms of high‐grade B‐cell lymphomas in biological fluids from Burkitt lymphoma and diffuse large B‐cell lymphoma

BHLHE41, a transcriptional repressor involved in physiological processes and tumor development

Immunophenotypic portrait of leukemia‐associated‐phenotype markers in B acute lymphoblastic leukemia

Integrative single-cell chromatin and transcriptome analysis of human plasma cell differentiation

Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registry.

Flow cytometric analysis of peripheral blood neutrophil myeloperoxidase expression in myelodysplastic neoplasms (MPO-MDS-Valid): protocol for a multicentre diagnostic accuracy study.

EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma.

Combined inhibition of Wee1 and Chk1 as a therapeutic strategy in multiple myeloma.

Targeting cellular iron homeostasis with ironomycin in diffuse large B cell lymphoma.

RNA-Sequencing-Based Transcriptomic Score with Prognostic and Theranostic Values in Multiple Myeloma

Monocyte CD169 Expression as a Biomarker in the Early Diagnosis of Coronavirus Disease 2019.

DNA Repair Expression Profiling to Identify High-Risk Cytogenetically Normal Acute Myeloid Leukemia and Define New Therapeutic Targets.

Collaborators (7)

Raúl F. Pérez

Ludovic Gabellier

Blandine GUFFROY

thierry fest

Jerome Moreaux

sylvain carras

José Labarere

Make your next move.